Prot# PR104-2003: A Randomized Phase II, Multi-Center, Open-Label Trial of PR104 and Docetaxel in Patients with Advanced Non-Small Cell Lung Cancer

Project: Research project

Project Details

StatusFinished
Effective start/end date3/6/093/5/12

Funding

  • Proacta, Inc. (PR104-2003)